Shanghai Drug Maker Gets $97 Mln From Fidelity, GIC, Qiming, Others

The Covid-19 pandemic has put China's pharmaceutical, medical an healthcare industries in the global spotlight.

Source: Forbes.com Healthcare News - July 20, 2020 Category: Pharmaceuticals Authors: Russell Flannery, Forbes Staff Tags: Asia /asia Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital russellflanneryblog Source Type: news